Physical activity shifts gut microbiota structure in aged subjects with overweight/obesity and metabolic syndrome.

Gut microbiota Metabolic syndrome Obesity Overweight Physical activity

Journal

Biology of sport
ISSN: 0860-021X
Titre abrégé: Biol Sport
Pays: Poland
ID NLM: 8700872

Informations de publication

Date de publication:
Jul 2024
Historique:
received: 10 08 2023
revised: 25 08 2023
accepted: 22 10 2023
medline: 2 7 2024
pubmed: 2 7 2024
entrez: 2 7 2024
Statut: ppublish

Résumé

We aimed to identify how physical activity (PA), within the context of a Mediterranean diet, affects metabolic variables and gut microbiota in older individuals with overweight/obesity and metabolic syndrome. Observational analysis was conducted as part of the PREDIMED-Plus study with 152 males and 145 females with overweight/obesity and metabolic syndrome. General assessments, anthropometric and biochemical measurements, and gut microbial 16S rRNA sequencing data were analyzed at baseline and 1-year of follow-up. Participants were stratified by tertiles of 1-year change in total PA-related energy expenditure ranging from -98.77 to 1099.99 METs (min/week). The total PA percentage of change was reduced in tertile 1 (-44.83 ± 24.94), increased in tertile 2 (28.96 ± 23.33) and tertile 3 (273.64 ± 221.42). Beta diversity analysis showed differences in the gut microbiota population within each tertile group. Significant differences were found at phylum, family, and genus levels in the gut microbiota of the three tertile groups at baseline and 1-year timepoint. Tertile 3, the group with the greatest increase in PA, was characterized by increases in their levels of

Identifiants

pubmed: 38952913
doi: 10.5114/biolsport.2024.133005
pii: 51833
pmc: PMC11167471
doi:

Types de publication

Journal Article

Langues

eng

Pagination

47-60

Informations de copyright

Copyright © Institute of Sport – National Research Instutite.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Auteurs

Jananee Muralidharan (J)

CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.
University of Rovira i Virgili, Department of Biochemistry and Biotechnology, Human Nutrition Unit, 43003 Reus, Spain.

Patricia Ruiz-Limón (P)

Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, The Biomedical Research Institute of Malaga and Platform in Nanomedicine (IBIMA BIONAND Platform), University of Malaga, 29016 Malaga, Spain.
CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

Ana M Gomez-Perez (AM)

Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, The Biomedical Research Institute of Malaga and Platform in Nanomedicine (IBIMA BIONAND Platform), University of Malaga, 29016 Malaga, Spain.
CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

Mora Murri (M)

Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, The Biomedical Research Institute of Malaga and Platform in Nanomedicine (IBIMA BIONAND Platform), University of Malaga, 29016 Malaga, Spain.
CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

Jesús Vioque (J)

Institute of Health and Biomedical Research of Alicante. University of Miguel Hernández (ISABIAL-UMH), 03010 Alicante, Spain.
CIBER Epidemiology and Public Health (CIBERESP), Carlos III Health Institute, 28029 Madrid, Spain.

Dolores Corella (D)

CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.
Department of Preventive Medicine, University of Valencia, 46100 Valencia, Spain.

Montse Fitó (M)

CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.
Cardiovascular Risk and Nutrition (Regicor Study Group), Hospital del Mar Research Institute (IMIM), 08003 Barcelona, Spain.

Josep Vidal (J)

Endocrinology and Nutrition Department, Clinic Universitary Hospital, 08036 Barcelona, Spain.
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.

Jordi Salas-Salvadó (J)

CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.
University of Rovira i Virgili, Department of Biochemistry and Biotechnology, Human Nutrition Unit, 43003 Reus, Spain.
Pere i Virgili Health Research Institute (IISPV). San Joan University Hospital, 43003 Reus, Spain.

Laura Torres-Collado (L)

Institute of Health and Biomedical Research of Alicante. University of Miguel Hernández (ISABIAL-UMH), 03010 Alicante, Spain.
CIBER Epidemiology and Public Health (CIBERESP), Carlos III Health Institute, 28029 Madrid, Spain.

Oscar Coltell (O)

Department of Computer Sciences. University Jaume I, Castellon, Spain.

Alessandro Atzeni (A)

CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.
University of Rovira i Virgili, Department of Biochemistry and Biotechnology, Human Nutrition Unit, 43003 Reus, Spain.

Olga Castañer (O)

CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.
Cardiovascular Risk and Nutrition (Regicor Study Group), Hospital del Mar Research Institute (IMIM), 08003 Barcelona, Spain.

Mònica Bulló (M)

CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.
University of Rovira i Virgili, Department of Biochemistry and Biotechnology, Human Nutrition Unit, 43003 Reus, Spain.

M Rosa Bernal-López (MR)

CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.
Department of Internal Medicine of Regional University Hospital, Institute of Biomedical Research in Malaga (IBIMA), 29009 Málaga, Spain.

Isabel Moreno-Indias (I)

Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, The Biomedical Research Institute of Malaga and Platform in Nanomedicine (IBIMA BIONAND Platform), University of Malaga, 29016 Malaga, Spain.
CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

Francisco J Tinahones (FJ)

Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, The Biomedical Research Institute of Malaga and Platform in Nanomedicine (IBIMA BIONAND Platform), University of Malaga, 29016 Malaga, Spain.
CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

Classifications MeSH